GW Pharma CEO: Europe Epidyolex Launch | Mad Money | CNBC November 21, 2022 admin CBD 1 The European Union has approved GW Pharma’s CBD-based drug Epidyolex to treat seizures related to epilepsy. CEO Justin …
I just got seizure looking at their financials.